[參考文獻(xiàn)]
[1] 李正蓉. 苦參素的藥理與臨床研究進(jìn)展[J]. 華西藥學(xué)雜志,2003,18(6):435-437.
[2] Han Y,Zhang S,Wu J,et al. Matrine induces apoptosis of human multiple myeloma cells via activation of the mitochondrial pathway[J]. Leuk Lymphoma,2010,51(7):1337-1346.
[3] Zhang S,Qi J,Sun L,et al. Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells[J]. Mol Biol Rep,2009,36(4):791-799.
[4] Morselli E,Galluzzi L, Kepp O, et al. Anti- and pro-tumor functions of autophagy[J]. Biochim Biophys Acta,2009,1793(9):1524-1532. 醫(yī).學(xué)全.在.線網(wǎng)站payment-defi.com
[5] Biederbick A,Kern HF,Elsasser HP. Monodansylcadaverine(MDC)is a specific in vivo marker for autophagic vacuoles[J]. Eur J Cell Biol,1995,66(1):3-14.
[6] Jemal A,Pay F,Center M M,et al. Global cancer statistics[J]. CA Cancer J Clin, 2011,61(2):69-90.
[7] Marin JJ,Romero MR, Martinez-Becerra P, et al. Overview of the molecular bases of resistance to chemotherapy in liver and gastrointestinal tumours[J]. Curr Mol Med,2009,9(9):1108-1129.
[8] 廖春燕,梁健,楊燕,等. 苦豆子的藥理及應(yīng)用概述[J]. 中國民族民間醫(yī)藥,2009,18(5):6-8.
[9] 周炳剛,孫靖中,蘇剛,等. 苦參堿誘導(dǎo)人乳腺癌細(xì)胞MCF27/ADR的凋亡研究[J]. 中華實驗外科雜志, 2003, 20(6):515-516.
[10] 鄭安祥,陳杰,陶惠民. 苦參堿抑制人骨肉瘤MG-63細(xì)胞增值和誘導(dǎo)凋亡的體外實驗研究[J]. 實用腫瘤雜志,2005,20(6):516-519.
[11] 張立明,鄭傳莉. 苦參堿誘導(dǎo)人肝癌細(xì)胞SMMC-7721凋亡的實驗研究[J]. 西北藥學(xué)雜志,2006,22(3):128-129.
[12] 查勇,寸英麗,黃云超,等. 苦參堿對肝癌細(xì)胞株SMMC-7721凋亡和自噬相關(guān)基因表達(dá)的影響[J]. 世界華人消化雜志, 2010,18(29): 3078-3083.
[13] 薛凈,李瑜元,聶玉強,等. 苦參堿對人肝癌細(xì)胞株HepG2基因表達(dá)譜的影響[J]. 胃腸病學(xué)和肝病學(xué)雜志,2007,16(4):341-343.
[14] 郭丹,陳娜娜,周萍,等. 苦參堿抑制肝癌Hep3B細(xì)胞生長及β-catenin的轉(zhuǎn)錄活性[J]. 中藥材,2010,33(5):778-781,
[15] 夏寶妹,周懷君, 胡婭莉,等. 氧化苦參堿抑制子宮內(nèi)膜癌細(xì)胞株Ishikawa的實驗研究[J]. 現(xiàn)代婦產(chǎn)科進(jìn)展,2009,18(4):278-281.
[16] 楊道科,王英俊,朱洪海.氧化苦參堿誘導(dǎo)結(jié)腸癌細(xì)胞株SWI116凋亡的實驗研究[J]. 中國醫(yī)藥導(dǎo)報,2008,5(27):26-27.